Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Itai Gross

7PUBLICATIONS
40CO-AUTHORS
Carbon capture engineering (excl. sequestration)Environmental epidemiologyRespiratory diseasesGene mappingInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Oct 29, 2025
The response of rare CFTR mutations to specific modulator combinations.

Noemie Stanleigh, Michal Gur, Michal Shteinberg

|Aug 05, 2025
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry.

Mordechai Pollak, Simone Gambazza, Annalisa Orenti

|Jan 15, 2025
Variability in disease severity among cystic fibrosis patients carrying residual-function variants: data from the European Cystic Fibrosis Society Patient Registry.

Meir Mei-Zahav, Annalisa Orenti, Andreas Jung

|Jun 13, 2024
Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations.

Johanna Raidt, Sarah Riepenhausen, Petra Pennekamp

|Jun 06, 2024
ERS statement on transition of care in childhood interstitial lung diseases.

Petr Pohunek, Effrosyni Manali, Susanne Vijverberg

|Feb 01, 2024
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.

Eitan Kerem, Annalisa Orenti, Arianna Adamoli

Pageof 2

Frequent Collaborators

3 joint publications

Annalisa Orenti

1 joint publications

Elpis Hatziagorou

1 joint publications

Isabelle Sermet-Gaudelus

1 joint publications

Petr Pohunek

1 joint publications

Susanne Vijverberg

1 joint publications

Julia Carlens

1 joint publications

Ralph Epaud

1 joint publications

Carlee Gilbert

1 joint publications

Matthias Griese

1 joint publications

Bulent Karadag

Frequent Collaborators

3 joint publications

Annalisa Orenti

1 joint publications

Elpis Hatziagorou

1 joint publications

Isabelle Sermet-Gaudelus

1 joint publications

Petr Pohunek

Top Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An <em>In Vitro</em> Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An <em>In Vitro</em> Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on : Feb 11, 2017

20.0K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on : Apr 11, 2018

10.6K
See more related videos

Top Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An <em>In Vitro</em> Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An <em>In Vitro</em> Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on : Feb 11, 2017

20.0K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on : Apr 11, 2018

10.6K
See more related videos